A US start-up company has claimed that transfusions of plasma from donors under the age of 25 may reduce the risk of several major diseases associated with ageing, such as Alzheimer’s. Their ongoing clinical trial measures a plethora of blood biomarkers before and one-month after the transfusion. So far, 70 participants over the age of ...
Young blood transfusions turn back time
7 Jun 2017